The Italian proposal to administer the second dose of the Pfizer-Biontech vaccine 40 days after the first meets the approval of the European Medicines Agency (EMA). To report it is Marco Cavalry, head of the organism’s office for biological threats and vaccination strategy.
Covid vaccines, the experts: “No to lengthening the time between doses for fragile patients”
“Pfizer’s recommendations speak of a window of 21 days”, said Cavaleri, “because this is what resulted from the first studies known to us for the evaluation of the vaccine“, but some clinical trials “have been conducted with an interval of maximum 42 days “. This information is fully reported in the vaccine leaflet.
Covid vaccines, how effectiveness is calculated and why it is better not to make comparisons
edited by Cinzia Lucchelli
“We can therefore conclude that administering the vaccine within the maximum window of 42 days is not a serious problem” concluded Cavaleri.
Covid: getting vaccinated in the company, here’s how and when
by Donatella Zorzetto
However, reviews of anti-covid-19 vaccines and therapies are underway. So far the EMA has five drugs under review: Curevac, Novavax, Sputnik V, Sinovac and, from May 7, also the vaccine produced by the collaboration between Sanofi and Gsk. “We are looking forward to receiving the first results of Pfizer vaccine tests on adolescents,” Cavaleri concluded.
AstraZeneca and J&J vaccines: no need to be analyzed before receiving them
by Viola Rita
.